The University of Brighton is looking into buying a former Novartis pharmaceutical site in Horsham, West Sussex and plans to open a new innovative, high quality centre for high education.
This centre would-
- Create up to 2,250 new jobs
- Bring £1.7 billion of investment to the region
- Provide around 3,500 places for students
Brighton University currently has five campuses across Hastings, Eastbourne and Brighton & Hove.
Novartis spokesman said: “We are delighted to be able to confirm that we are entering into exclusive negotiations with the University of Brighton for the sale of our former Horsham site at Wimblehurst Road.
This is still subject to the usual negotiations when trying to agree a contract, but the university’s proposal offers an exciting opportunity which could bring long term benefits to the town and local residents, as well as realise our ambition in leaving a scientific legacy at the site. We will now work closely with the university and Horsham District Council to try to make this happen.”
Ron Crank, chief executive of Coast to Capital, has been working behind the scenes to help secure a positive outcome for the development site. “We are extremely pleased that negotiations have commenced to bring new and exceptional training facilities to Horsham. This is a significant step forward in the process of exploring options for the site’s future.
The university’s plans, if brought to a successful conclusion, will provide a fitting legacy with far reaching benefits for the next generation and local and regional economy. My colleagues and I look forward to working closely with all partners as negotiations progress.”